Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
harindra.amarasinghe@rdm.ox.ac.uk

Harindra Amarasinghe

Postdoctoral Scientist

Recent publications

Mapping the epigenomic landscape of human monocytes following innate immune activation reveals context-specific mechanisms driving endotoxin tolerance.

Amarasinghe HE. et al, (2023), BMC Genomics, 24

Telomere Length and DNA Methylation Epitype Both Provide Independent Prognostic Information in CLL Patients; Data from the UK CLL4, Arctic and Admire Clinical Trials

Carr LJ. et al, (2023), BLOOD, 142

Epigenomic analysis reveals a dynamic and context-specific macrophage enhancer landscape associated with innate immune activation and tolerance.

Zhang P. et al, (2022), Genome Biol, 23

Clinico-biological significance of DNA methylation in chronic lymphocytic leukaemia patients: results from three UK clinical trials

Rose-Zerilli M. et al, (2020), LEUKEMIA & LYMPHOMA, 61, 100 - 102

The clinical importance of DNA methylation signatures in chronic lymphocytic leukemia patients treated with chemo-immunotherapy

Wojdacz TK. et al, (2018), CANCER RESEARCH, 78

More publications